Form 483

Izeen Pharma Inc Form 483, 2009-10-13

FDA issued a Form 483 to Izeen Pharma Inc on 2009-10-13 with 8 public-safe observations.

483· Form 483 issued8 observations

Izeen Pharma Inc · Frederick, United States · Issued October 13, 2009

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Oct 2009
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Rachel C Harrington, Ernest Bizjak, Monique-Rac Lester

13 Oct 2009
21 CFR 211.80(a)

Procedures To Be in Writing

Cited by Rachel C Harrington, Ernest Bizjak, Monique-Rac Lester

13 Oct 2009
21 CFR 211.105(b)

Distinctive ID or code not recorded in batch record

Cited by Rachel C Harrington, Ernest Bizjak, Monique-Rac Lester

13 Oct 2009
21 CFR 211.137(a)

Expiration date lacking

Cited by Rachel C Harrington, Ernest Bizjak, Monique-Rac Lester

13 Oct 2009
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Rachel C Harrington, Ernest Bizjak, Monique-Rac Lester

Inspected site

IPIzeen Pharma IncFrederick, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.105(b)Cited across public-safe Form 483 observations1x
21 CFR 211.137(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere